All products are provided either as a liquid suspension in a 30mL vial or as raw powder packaged in an individual bag.  1mg/mL  solution (30mg/30mL) Finasteride Clinical data Other names MK-906; YM-152; L-652,931; 17β-(N-tert-Butylcarbamoyl)-4-aza-5α-androst-1-en-3-one; N-(1,1-Dimethylethyl)-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide AHFS/Drugs.com Monograph MedlinePlus a698016 License data US DailyMed: Finasteride Pregnancycategory AU: X (High risk) Routes ofadministration By mouth Drug class 5α-Reductase inhibitor ATC code G04CB01 (WHO) D11AX10 (WHO) Pharmacokinetic data Bioavailability 65%[5] Protein binding 90%[5] Metabolism Liver (CYP3A4, ALDH)[5] Elimination half-life Adults: 5–6 hours[5]Elderly: >8 hours[5] Excretion Feces: 57%[5]Urine: 40%[5] Identifiers show IUPAC name CAS Number 98319-26-7  PubChem CID 57363 IUPHAR/BPS 6818 DrugBank DB01216  ChemSpider 51714  UNII 57GNO57U7G KEGG D00321  ChEBI CHEBI:5062  ChEMBL ChEMBL710  CompTox Dashboard (EPA) DTXSID3020625  ECHA InfoCard 100.149.445  Chemical and physical data Formula C23H36N2O2 Molar mass 372.553 g·mol−1 3D model (JSmol) Interactive image show SMILES show InChI   (verify) **The information provided is intended solely for educational purposes and should not be considered a replacement for professional medical advice. Additionally, it is important to note that research chemicals are intended solely for laboratory study by professional researchers and are not intended for human consumption.**